Metformin has been found to activate Nrf2/Keap1 signaling in neurons, the liver, and skeletal muscle in an AMPK-dependent manner [153,154] however, it has also been found to inhibit Nrf2 and reverse chemoresistance in various cancer cell lines [155,156]. Here, KEAP1 is linked to cancer.